Marie-Claude Fournié-Zaluski
Geen lopende functies
Loopbaan van Marie-Claude Fournié-Zaluski
Eerdere bekende functies van Marie-Claude Fournié-Zaluski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Université Pierre et Marie Curie | Corporate Officer/Principal | - | - |
Pharmaleads SA
 Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Oprichter | 01-01-2000 | - |
| Corporate Officer/Principal | 01-01-2000 | - |
Opleiding van Marie-Claude Fournié-Zaluski
Statistieken
Internationaal
| Frankrijk | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Pharmaleads SA
Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
